0001127602-20-023070.txt : 20200806 0001127602-20-023070.hdr.sgml : 20200806 20200806165349 ACCESSION NUMBER: 0001127602-20-023070 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200805 FILED AS OF DATE: 20200806 DATE AS OF CHANGE: 20200806 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Clyburn Frank CENTRAL INDEX KEY: 0001763963 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-06571 FILM NUMBER: 201082469 MAIL ADDRESS: STREET 1: 2000 GALLOPING HILL ROAD CITY: KENILWORTH STATE: NJ ZIP: 07033 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Merck & Co., Inc. CENTRAL INDEX KEY: 0000310158 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 221918501 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2000 GALLOPING HILL ROAD CITY: KENILWORTH STATE: NJ ZIP: 07033 BUSINESS PHONE: 908-740-4000 MAIL ADDRESS: STREET 1: 2000 GALLOPING HILL ROAD CITY: KENILWORTH STATE: NJ ZIP: 07033 FORMER COMPANY: FORMER CONFORMED NAME: Merck & Co. Inc. DATE OF NAME CHANGE: 20091103 FORMER COMPANY: FORMER CONFORMED NAME: SCHERING PLOUGH CORP DATE OF NAME CHANGE: 19920703 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2020-08-05 0000310158 Merck & Co., Inc. MRK 0001763963 Clyburn Frank MERCK & CO., INC. 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 1 EVP, Chief Commercial Officer Common Stock 2020-08-05 4 M 0 18876 0 A 99639.106 D Common Stock 2020-08-05 4 S 0 18876 81.5466 D 80763.106 D Common Stock - 401(k) Plan 1629.2567 I By 401(k) Stock Option (Right to Buy) 39.29 2020-08-05 4 M 0 18876 0 D 2013-05-02 2022-05-01 Common Stock 18876 0 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.5400 to $81.5550, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote. Holdings include shares acquired in dividend reinvestment transactions. Includes shares acquired and dividends earned through July 7, 2020, in the Merck U.S. Savings Plan, a 401(k) plan. The option became exercisable in equal installments on 5/2/2013, 5/2/2014 and 5/2/2015. /s/ Faye C. Brown as Attorney-in-Fact for Frank Clyburn 2020-08-06